Document is current
Any future updates will be listed below
-
Authors
Tokunaga, Masanori https://orcid.org/0000-0002-3183-349X
Machida, Nozomu
Mizusawa, Junki
Ito, Seiji
Yabusaki, Hiroshi
Hirao, Motohiro
Watanabe, Masaya
Imamura, Hiroshi
Kinoshita, Takahiro
Yasuda, Takushi
Hihara, Jun
Fukuda, Haruhiko
Yoshikawa, Takaki
Boku, Narikazu
Terashima, Masanori
-
Funding
Funding for this research was provided by:
AMED (JP16ck0106043)
AMED (JP19ck0106311)
National Cancer Center Research and Development Fund (26-A-4)
National Cancer Center Research and Development Fund (29-A-3)
National Cancer Center Research and Development Fund (2020-J-3)
National Cancer Center Research and Development Fund (2023-J-03)
- License Information
-
More Information
Article History
Received: 29 October 2023
Accepted: 5 January 2024
First Online: 19 January 2024
Declarations
:
: M Tokunaga has received lecture fees from Johnson & Johnson, Intuitive Surgical, Medtronic, Olympus Medical Systems, Ono Pharmaceutical, Lilly Japan, and Daiichi Sankyo. N Machida has received lecture fees from Taiho Pharmaceutical, Bristol-Myers Squibb Japan, Ono Pharmaceutical, Daiichi Sankyo, Lilly Japan, Yakult Honsha, Takeda, MSD K.K, Chugai Pharma, Merck KGaA and has received research expenses from MSD, AstraZeneca, Amgen, Ono Pharmaceutical, Taiho Pharmaceutical, ALX Oncology, Bristol-Myers Squibb Japan. J Mizusawa has received honoraria from Taiho Pharmaceutical and Chugai Pharmaceutical; his spouse is an employee of Pfizer. S Ito has received lecture fees from Taiho Pharmaceutical and Otsuka and has received research expenses from Ono Pharmaceutical, AstraZeneca, and Merck. H Fukuda has received lecture fees from CMIC Co., Ltd, Chugai Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd. T Yoshikawa Lecture fees from Chugai, Taiho Pharmaceutical, Daiichi Sankyo, Ono Pharmaceutical, Medtronic, BMS, EA Pharma, Johnson and Johnson, Intuitive Surgical, Japan Blood Products Organization, Olympus, Lilly, and Novartis. N Boku has received lecture fees from Taiho Pharmaceutical, Bristol-Myers Squibb Japan, Ono Pharmaceutical, Daiichi Sankyo, and Lilly Japan and has received research expenses from Ono Pharmaceutical and Takeda Pharmaceutical. M Terashima has received lecture fees from Taiho Pharmaceutical, Chugai, Ono Pharmaceutical, Bristol Myers Squibb Japan, Yakult, Takeda, Lilly Japan, Pfizer, Daiichi Sankyo, Johnson and Johnson, Medtronic Japan, Intuitive Japan, and Olympus. All remaining authors declare no conflicts of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Free to read: This content has been made available to all.
